Panion & Bf Biotech (TPE:1760) Total Liabilities : NT$1,345 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Panion & Bf Biotech Total Liabilities?

Panion & Bf Biotech's Total Liabilities for the quarter that ended in Mar. 2024 was NT$1,345 Mil.

Panion & Bf Biotech's quarterly Total Liabilities increased from Sep. 2023 (NT$1,190.37 Mil) to Dec. 2023 (NT$1,324.10 Mil) and increased from Dec. 2023 (NT$1,324.10 Mil) to Mar. 2024 (NT$1,344.76 Mil).

Panion & Bf Biotech's annual Total Liabilities increased from Dec. 2021 (NT$1,020.08 Mil) to Dec. 2022 (NT$1,086.43 Mil) and increased from Dec. 2022 (NT$1,086.43 Mil) to Dec. 2023 (NT$1,324.10 Mil).

Panion & Bf Biotech Total Liabilities Historical Data

The historical data trend for Panion & Bf Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panion & Bf Biotech Total Liabilities Chart

Panion & Bf Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

552.94

1,833.99

1,020.08

1,086.43

1,324.10

Panion & Bf Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,191.72	1,372.22	1,190.37	1,324.10	1,344.76

Panion & Bf Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Panion & Bf Biotech's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1050.848	+	(147.626	+	115.128
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	10.499)
	=	1,324

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3235.181	-	1911.08
	=	1,324

Panion & Bf Biotech's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1088.546	+	(136.494	+	109.223
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	10.5)
	=	1,345

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	3176.439	-	1831.676
	=	1,345

Panion & Bf Biotech Total Liabilities Related Terms

Thank you for viewing the detailed overview of Panion & Bf Biotech's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Panion & Bf Biotech (TPE:1760) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panion & Bf Biotech Inc (TPE:1760) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, 16th Floor, F Building, Nangang District, Taipei, TWN, 11503

Website

https://www.pbf.com.tw

Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. It is engaged in research and development of pharmaceuticals and new drugs. It focuses on pharmaceuticals, cosmeceuticals, nutraceuticals, and medical devices sectors. It has four core business groups such as disease treatment, disease prevention, disease diagnosis, and delayed aging. It has two geographic segments Taiwan segment and China, Hong Kong, and Macau segment. It generate majority of the revenue from Taiwan segment.

Panion & Bf Biotech (TPE:1760) Headlines

No Headlines